RA, P., N, X., F, H., CP, F., P, C., B, H., & DL, B. (2022). Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions. BMC medical informatics and decision making, 22(1), 223. https://doi.org/10.1186/s12911-022-01972-w
Chicago Style (17th ed.) CitationRA, Pozzar, Xiong N, Hong F, Filson CP, Chang P, Halpenny B, and Berry DL. "Concordance Between Influential Adverse Treatment Outcomes and Localized Prostate Cancer Treatment Decisions." BMC Medical Informatics and Decision Making 22, no. 1 (2022): 223. https://doi.org/10.1186/s12911-022-01972-w.
MLA (9th ed.) CitationRA, Pozzar, et al. "Concordance Between Influential Adverse Treatment Outcomes and Localized Prostate Cancer Treatment Decisions." BMC Medical Informatics and Decision Making, vol. 22, no. 1, 2022, p. 223, https://doi.org/10.1186/s12911-022-01972-w.